FDA 510(k)

FreeStyle Libre 3 Continuous Glucose Monitoring System

Número K: K213996 · 2022-05-26

Data da decisão2022-05-26

Código do produtoQLG

Comité consultivoCH

DecisãoSubstantially Equivalent

Resumo do dispositivo

FreeStyle Libre 3 Continuous Glucose Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is Abbott Diabetes Care, Inc.. It received FDA 510(k) clearance on 2022-05-26 under 510(k) number K213996. The device is classified under product code QLG. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Perguntas frequentes

What is the FreeStyle Libre 3 Continuous Glucose Monitoring System?

FreeStyle Libre 3 Continuous Glucose Monitoring System is a medical device that received FDA 510(k) clearance on 2022-05-26. The listed applicant is Abbott Diabetes Care, Inc.. The 510(k) number is K213996.

When did FreeStyle Libre 3 Continuous Glucose Monitoring System receive FDA 510(k) clearance?

FreeStyle Libre 3 Continuous Glucose Monitoring System received FDA 510(k) clearance on 2022-05-26, under 510(k) number K213996.

Who is the listed applicant for FreeStyle Libre 3 Continuous Glucose Monitoring System?

The FDA 510(k) record lists Abbott Diabetes Care, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FreeStyle Libre 3 Continuous Glucose Monitoring System?

The FDA product code for FreeStyle Libre 3 Continuous Glucose Monitoring System is QLG.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Outros registros que listam Abbott Diabetes Care, Inc. como candidato(a)

K233537FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System K223435FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System K222447FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring System K223537FreeStyle Libre 2 System, FreeStyle Libre 3 System K212132FreeStyle Libre 3 Continuous Glucose Monitoring System K210943FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)

Ver todos os 12 dispositivos →

Dispositivos Relacionados (Código: QLG)

K222280Bigfoot Unity® Diabetes Management SystemBigfoot Biomedical, Inc.K223537FreeStyle Libre 2 System, FreeStyle Libre 3 SystemAbbott Diabetes Care, Inc.K212132FreeStyle Libre 3 Continuous Glucose Monitoring SystemAbbott Diabetes Care, Inc.K210943FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)Abbott Diabetes Care, Inc.K211102FreeStyle Libre 2 Flash Glucose Monitoring SystemAbbott Diabetes Care, Inc.K201761FreeStyle Libre 2 Flash Glucose Monitoring System (with FreeStyle Libre 2 App)Abbott Diabetes Care, Inc.

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.